2019 National Drug & Alcohol IQ Challenge

January 18, 2019

ON DRUGS AND DRUG U. BY TAKING THE: 2019. National Drug. & Alcohol. IQ Challenge.

Spotlight

eHealth Innovation @ UHN

Our team improves quality of life by being the go-to place for developing cool and intuitive self-care and remote monitoring technologies for people with chronic diseases. We attract multidisciplinary talents including engineers, software developers, designers, project managers, and researchers. Leveraging our clinical connections with healthcare organizations globally, we develop technologies from users’ perspective, and evaluate our technologies to collect real data to assess their effectiveness and foster changes to better healthcare delivery.

OTHER WHITEPAPERS
news image

2020 Prescription Drug List

whitePaper | April 7, 2020

The information in this document is designed to help you understand the prescription drug benefits offered under this plan and to compare these benefits to those offered by other plans. Information contained in this summary is designed to help you compare both the value and scope offormulary benefits.

Read More
news image

Access to medicinal products

whitePaper | January 3, 2022

There are many factors that can prevent a patient from being able to obtain the medicine they need, ranging from selective marketing decisions by companies to products being too expensive or pharmacy stock-outs

Read More
news image

A Vision for the Global Generic and Biosimilar Medicines Industry

whitePaper | May 22, 2021

One of the key roles of the generic and biosimilar medicines industry is specifically to promote the widest possible access to affordable medicines with high quality, safety, and efficacy for patients globally by introducing competition into the markets. Despite the many hurdles, the generic medicines companies have clearly lived up to the challenges posed by the pandemic as it is an industry that is quick to adapt and agile in manufacturing scale-up. During the outbreak of COVID-19, this industry was providing most of the medicines needed in Intensive Care Units to ventilate critically ill COVID patients. It is also providing most of the quality medicines dispensed around the world, especially for increasingly prevalent chronic diseases and is therefore a strong contributor to health outcomes globally.

Read More
news image

Deck 7 Webinars and Virtual Events

whitePaper | January 1, 2020

If you recognize some of these challenges, download the Deck 7 Webinar & Virtual Events overview to see how we make it easy for busy marketers to run highly successful webinars and virtual events....

Read More
news image

Application Notes & Whitepapers 2019

whitePaper | December 19, 2019

Welcome to European Pharmaceutical Review’s Application Notes & Whitepapers Supplement 2019. This year’s topics range from analytical techniques for bioprocess investigation, host cell protein analysis and Raman imaging to advice on outsourcing services for product characterisation.

Read More
news image

Pharmaceutical Sales Strategies Post-COVID-19: The Benefits of Virtual Engagement

whitePaper | April 7, 2021

In less than a week, in the face of a pandemic, the pharmaceutical sales model changed forever. In-person healthcare provider (HCP) visits came to a screeching halt and brand marketers scrambled to find ways to educate and engage these providers remotely. While the pandemic may have taken us by surprise, we should acknowledge that, even before the pandemic, pharmaceutical sales teams faced significant challenges. One solution for these challenges is to engage HCPs – virtually.

Read More

Spotlight

eHealth Innovation @ UHN

Our team improves quality of life by being the go-to place for developing cool and intuitive self-care and remote monitoring technologies for people with chronic diseases. We attract multidisciplinary talents including engineers, software developers, designers, project managers, and researchers. Leveraging our clinical connections with healthcare organizations globally, we develop technologies from users’ perspective, and evaluate our technologies to collect real data to assess their effectiveness and foster changes to better healthcare delivery.

Events